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ABSTRACT 
 
Nanoparticle toxicity in the environment is a major problem in industry, for many 
processes give off nanoparticles as waste. Nanoparticle waste affects environmental conditions 
and can be disruptive to organic systems. Citrate stabilized and functionalized gold nanoparticles 
were tested for membrane destabilization while in the presence of water or humic acid. It was 
found that in relation to experimental data using water the membrane destabilization with humic 
acid changed based on the nanoparticles’ functionality. Citrate stabilized nanoparticles both 
increased and decreased the amount of destabilization depending on how far the membrane was 
penetrated. Functionalized nanoparticles always decreased the amount of destabilization. The 
experiments were run using QCM-D monitoring, measuring the dissipation and change of 
frequency in the cell membrane. It is recommended that communication between agencies takes 
place in order to raise awareness and impart futures changes in current practices.
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CHAPTER 1:  INTRODUCTION AND BACKGROUND 
 
1.1 Problem Statement and Hypothesis 
 
Potential commercial applications of nanoparticles have raised concerns about 
nanoparticles’ effects on organic systems and the environment. There are currently several 
studies examining the toxicological effects of nanoparticles in organic systems. The studies on 
nanoparticles in the environment show diverse situations based on nanoparticle properties and 
therefore are impractical to compare. This paper looks at the general relationships between 
nanoparticles and the environment through the use of humic acid, a type of natural organic 
matter. 
The main concern regarding nanoparticles is the potential to damage cells. While there 
are several mechanisms through which nanoparticles can damage cells, this paper focuses on 
membrane destabilization. To observe membrane destabilization quartz crystal microbalance 
with dissipation (QCM-D) monitoring is used. QCM-D monitoring detects changes in dissipation 
and frequency, which corresponds to changes in mass in the cell membrane. The changes in mass 
indicate possible bilayer destruction and membrane destabilization. Several nanoparticle 
properties influence cell membrane destabilization; these properties include size, concentration, 
and chemical functionality. This paper focuses on the effects of the chemical functionality of 
nanoparticles while in a pseudo-natural environment on nanoparticle-lipid interactions. 
We hypothesize that the environmental conditions simulated by the humic acid will 
decrease the degree of membrane destabilization. The humic acid will decrease the amount of 
interaction between the nanoparticles and the cell membrane. Humic acid will adsorb into both 
the nanoparticles and the cell membrane, altering surface chemistry. The altered surface 
chemistry inhibits the nanoparticles’ ability to interact with the cell, reducing the degree of 
destabilization. 
 
1.2 Background 
 
1.2.1 Applications of Nanoparticles 
 
Nanoparticles have become useful for a variety of biological applications.  One common 
application is biosensing.  Biological agents, diseases, and toxic materials can be detected using 
biosensing, and detection of these is important for biomedical diagnosis, forensic analysis, and 
environmental monitoring
1
.  Several types of biosensing include colorimetric sensing, 
fluorescence sensing, and electrochemical sensing
1
.  Colorimetric sensing, during which a color 
change takes place upon detection of certain materials, is useful for detecting oligonucleotide 
sequences
1
.  Detecting these sequences is important in diagnosis of genetic and pathogenic 
diseases
1
.  Colorimetric sensing can also be used to detect cocaine; in the presence of cocaine, 
the nanoparticle sensors deaggregate, resulting in a color change from blue to red
1
.  Fluorescence 
sensing is useful for detecting DNA
1
, bacteria
1
, and tumor biomarkers in breast cancer
2
.   
Electrochemical sensing is useful since the attachment of nanoparticles onto electrodes 
drastically enhances the conductivity
1
.   Several systems have been reported using nanoparticle-
enzyme hybrids for electrochemical sensing, such as detection of glucose
1
.   
Another application of nanoparticles is drug delivery and medicine.  For example, 
nanoparticles can provide effective carriers for DNA, RNA, or proteins
1
.  This characteristic of 
nanoparticles is what makes gene therapy and protein-based therapeutics possible
1
.  Another 
example of such an application is treatment of breast cancer
2
 and colorectal cancer
3
.  
Nanoparticle formulations are being used in these cancer treatments, and these formulations, 
when compared to normal formulations, have at least equal efficacy and fewer toxic effects
2, 3
.   
One more well-known application of nanoparticles is bioimaging.  Some major imaging 
techniques include magnetic resonance imaging (MRI) and optical imaging (OI)
1
.  Bioimaging is 
important for imaging both in vitro and in vivo biological specimens
1
, such as cancer-related 
antigens
2, 3
.  Two types of nanoparticles are commonly used for bioimaging: luminescent 
nanoprobes for OI and magnetic nanoparticles for MRI
1
.  
 
1.2.2 Supported Lipid Bilayer Formation 
 
Since most systems treated with AuNPs are organic a simulated environment needs to be 
created for testing. To do this a supported lipid bilayer (SLB) is formed. For our experiment an 
SLB was used in the place of organic cells. Using an SLB has many advantages over using cells. 
The formation of an SLB is relatively quick (15 - 20 minutes) and provides a stable unchanging 
testing environment for each run. To use cells a large amount of time would need to be spent on 
culturing them and because cells can die they create a constantly shifting environment. In 
addition unlike an SLB cells have little resistance to acids and acid solutions, which may cause 
rapid cell death in the middle of the experiment. 
 
1.2.3 Toxicity 
 
One of the main concerns with the use of NPs is their toxicity. While used in medical 
applications NPs are used to kill cancerous cells. If the NPs are too toxic then they will begin to 
affect healthy cells. In environmental uses NPs are used to remove harmful bacteria from soil 
and water, where if they are too toxic then beneficial bacteria will also be removed. From this it 
can be determined that a healthy medium of NP toxicity needs to be reached (toxic enough to do 
the job, but not to toxic to go overboard). The toxicity of AuNPs is affected by the surface 
chemistry and rate of aggregation in the system. A 2004 study by Goodman et al. observed the 
effects surface chemistry have on the toxicity of AuNP clusters. By testing AuNPs with various 
assays it was found that for a cationic surface the AuNPs showed a moderate toxicity, while for 
an anionic surface there was no toxicity
5
.  A study done by Lewinski et al. (2008) examined the 
effects of AuNP toxicity on organic systems. It was found that at relatively low doses AuNPs 
were the least toxic kind of NPs on organic systems
6
. It was also found that at high 
concentrations AuNPs can cause a cytotoxic effect
6
. The possible cytotoxic effect of AuNPs was 
also explored in a 2007 study by Yu et al. The study found that the cytotoxic effect of AuNPs is 
primarily dependent upon the size of the nanoparticle cluster, being most toxic at a size of 1-2 
nm
7
. 
Reference NP Type NP Size Experimental 
Conditions 
Study Results 
Goodman et al. 
(2004)
5
 
Gold 2 nm Cationic and 
anionic assays 
used with 
mammalian 
cells 
Effect of 
surface 
chemistry on 
toxicity 
Cationic 
surfaces 
showed 
moderate 
toxicity 
Tkachenko et al. 
(2004)
8
 
Gold 22 nm HeLa, 
3T3/NIN, and 
HepG2 cells 
used 
Effects of 
peptides on 
cellular uptake 
Cell viability 
reduced by up 
to 20% 
Yu et al. 
(2007)
7
 
Gold 0.8 - 15 nm Carcinoma 
cells, 
melanoma 
cells, mouse 
fibroblasts, and 
mouse 
macrophage 
cells used 
Effects of NP 
size on toxicity 
Moderate 
toxicity 
between 1nm 
and 2 nm. 
Little to no 
toxicity below 
1 nm or above 
15 nm 
Connor et al. 
(2005)
9
 
Gold 4 nm, 12 nm, 
and 18 nm 
Human 
leukemia cells 
tested with 
non-treated and 
citrate treated 
Effects of NP 
uptake and 
acute toxicity 
No toxicity at 
250 µg mL
-1
 
for non-treated. 
NPs not 
inherently 
NPs toxic. 
Fu/Shenoy et al. 
(2005)
10,11
 
Gold 10 nm Human breast 
carcinoma 
xenograft cells 
Effects of NPs 
treated with a 
PEG spacer on 
toxicity 
NPs 
internalized but 
non-toxic up to 
200 µg mL
-1
 
Pernodet et al. 
(2006)
12
 
Gold 13 nm Human dermal 
fibroblasts 
Effects of 
differing 
concentrations 
of citrate 
treated NPs 
Dose 
dependent 
decrease in cell 
area and 
density 
1.2.4 Nanoparticles and the Environment 
 
One of the main concerns of the industrial use of NPs is the effect they have on the 
environment. When introduced to soil and water NPs interact with the resident bacteria and may 
disrupt the environment. A 2008 study by Klaine et al. looked at the effects of nanoparticles in 
the environment. 
 
1.2.5 Natural Organic Matter 
 
To simulate the true conditions of nanoparticles in the environment, natural organic 
matter (NOM) is introduced to the NP system. NOM consists of organic substances found in soil 
and water. One of the most common types of NOM used is humic acid (HA). HA is used in 
conjunction with SLBs to simulate soil with different properties. This allows for a variety of 
testing in a controlled environment. A study was conducted by Stankus et al. (2010) viewing the 
effects of several types of NOM on AuNP systems. In that experiment it was found that AuNPs 
in the presence of NOM have their stability and rate of aggregation controlled by the NOM. This 
study shows that while in the presence of NOM the NP interactions are primarily controlled by 
the rate of adsorption of the NOM. 
Another study involving the effect of NOM on AuNP systems was performed by 
Waterman in 2013.  Two types of NOM were used in this study:  poly(methacrylic acid) (PMA) 
and HA.  When PMA was used, this study determined that both NP size and the environmental 
conditions simulated by the PMA affect the cytotoxicity of the NPs to the membrane.  When the 
HA was used, this study determined that HA may alter the mechanism by which NPs can be 
toxic and the toxicity of the NPs.     
  
CHAPTER 2:  OBJECTIVES  
 After performing the necessary background research, the objectives for this study have 
been developed.  They are as follows: 
 To examine the effects of chemical functionalization on the interaction between AuNPs 
and the lipid membrane. 
 To determine the effects of the environment on the interaction between the nanoparticles 
and membrane. 
 To evaluate the changes in mass and determine a possible mechanism for the interaction 
of nanoparticles with the membrane. 
  
CHAPTER 3:  EXPERIMENTAL 
 
3.1 Materials 
3.1.1 Solutions 
 
 Several solutions were prepared, including Tris-NaCl (buffer), sodium dodecyl sulfate 
(SDS), L-α-phosphatidylcholine (PC, both concentrated and dilute), and humic acid.   
 The buffer was prepared by adding 1.168 g NaCl to 0.24 g Tris (a 10:1 molar ratio) and 
adding de-ionized water until the mixture totaled 200 mL.  The mixture was stirred for 5 minutes 
or until the solids completely dissolved.  Diluted HCl was added in order to lower the pH to 
between 7.98 and 8.02.  (The initial solution had a pH of approximately 10.4.)  The buffer was 
stirred constantly to ensure that the pH was stable and to maintain a well-mixed solution.  
Immediately before using the buffer, the buffer was filtered through a 0.8-micron filter. 
 The SDS solution was prepared by adding 4 g SDS to de-ionized water and stirring until 
the mixture became well-mixed.  The water was added until the mixture totaled 200 mL to obtain 
a 2 percent solution.  
 The concentrated PC lipid solution was prepared by drying 0.15 mL concentrated PC 
powder (Avanti polar lipids, 100 mg powder/mL ethanol) over nitrogen, drying overnight under 
vacuum and adding 6 mL buffer.  The mixture was vortexed for 15 seconds and stored in the 
refrigerator (7°C).  (The final concentration was 2.5 mg/mL.) 
 The dilute PC lipid solution, which was used for experiments, was prepared by adding 
5.76 mL buffer to 0.24 mL concentrated PC lipid solution.  This solution was vortexed for 15 
seconds prior to use.  (The final concentration was 0.1 mg/mL.)  
 The humic acid solution was prepared by adding 0.1 g humic acid powder (Elliot Soil) to 
1000 mL water to obtain a concentration of 100 mg/mL, stirring for 1 hour at 30°C, and 
sonicating in a water bath for 1 hour.  The solution was stored at 7°C in a light-proof container 
(container covered with tin foil).  Prior to use, 50 mL of the solution was stirred for 30 minutes 
and filtered twice:  once through a 0.8-micron filter and once through a 0.2-micron filter.  
3.1.2 Nanoparticles     
 Gold nanoparticles (AuNP) with a diameter of 12 nm were purchased from NANOCS 
(New York, NY).  The stock nanoparticle solution consisted of the nanoparticles in de-ionized 
water with small amounts of tannic acid and sodium citrate.  The solution was stored at 7°C.  For 
this experiment, the AuNPs were dissolved in either water or humic acid to a concentration of 
7.14 x 10
10
 particles per mL.  This experiment utilized both citrate stabilized NPs and NPs that 
were functionalized with 1-propanethiol, 2-mercaptoethanol, 2-aminoethanethiol and 3-
mercaptopropionic acid. 
3.1.3 Crystals 
 The QCM-D crystals were pre-coated with silicon dioxide and purchased from Biolin 
Scientific (Gothenburg, Sweden).  The crystals could be used up to 10 times if experimental 
conditions were favorable. 
3.1.4 QCM-D 
 The QCM-D measurements were taken using the q-sense E4 system (Biolin Scientific, 
Sweden).  The system includes a pump, four chambers, the chamber holder, and the q-soft 
software. 
3.2 Procedure 
3.2.1 Pre-cleaning of QCM-D and crystals  
 The QCM-D chambers and silicon dioxide crystals needed to be cleaned before each 
experimental run. This was done by attaching the chambers to the pump and passing various 
fluids through the chambers at a flow rate of 0.3 mL per minute for approximately five minutes 
each. Ethanol was used first to decontaminate the crystals and remove any harmful matter 
(leftover NPs, HA, bacteria, etc.) from the chambers. De-ionized (DI) water is then used to rinse 
the excess ethanol before pumping a two percent SDS cleaning solution over the crystals. The 
SDS is then rinsed off of the crystals with de-ionized water. After rinsing the SDS air was flowed 
through the chambers to remove excess liquid. The crystals were then removed from the 
chambers and rinsed with DI water and then dried over nitrogen gas. The chambers were also 
dried over nitrogen gas. Once dried the crystals were then oxygen plasma cleaned twice for a 
duration of forty five seconds per clean. 
3.2.2 Operating the QCM-D       
 The cleaned crystals were placed back into the chambers, which were then locked into 
position in the chamber holders. Once the chambers were locked in the QCM-D power supply 
was turned on and the system was opened. Before running any trials the software was used to set 
the operating condition (23°C) and the frequencies for each chamber were checked. To check the 
frequencies the “find and run” operation in the software was selected to ensure that the frequency 
and dissipation were within the target range (5-30). Once that was completed the pump was set 
to flow at 0.15 mL per minute and the experimental fluids were run through the system. A tris-
NaCl buffer with approximate pH of 8.00 was run for ten minutes to stabilize the frequency and 
dissipation. A new measurement was then started. An SLB was formed on the crystals by 
running a PC lipid solution for six minutes followed by buffer and DI water for eight minutes 
each. Upon forming the SLB an HA solution was run through the system for eight minutes to 
simulate the experimental environment. At this point the NP solution was run for ten minutes and 
followed by eight more minutes of HA. DI water was then run through the system for eight 
minutes to remove excess HA and followed by buffer for eight minutes to once again stabilize 
the system. 
3.2.3 Changing Solutions 
 To change solutions while running the QCM-D (either cleaning or experimental runs) the 
pump first needed to be stopped. The pump tubes were then moved into the new solution, and the 
pump set to backflow. The backflow was run for five seconds, or until any air bubbles are 
evacuated, before being stopped again. The pump was then returned to normal flow. 
3.2.4 Post-cleaning of QCM-D and crystals 
 After experiments, the procedure in section 4.2.1 was used to clean the QCM-D and 
crystals, omitting only the oxygen plasma cleaning. 
 
 
 
  
CHAPTER 4:  RESULTS AND DISCUSSION 
4.1 QCM-D Plots 
 In this section the QCM-D plots will be shown and discussed.  In most of these plots, 
notice that at around the five-minute mark, there is a shift in frequency and dissipation.  At that 
time, the frequency (blue) drops from approximately 0 Hz to -55 Hz, and the dissipation (red) 
changes from -35 u to 4 u.  This shift in frequency and dissipation is the main sign that a stable 
lipid bilayer is forming onto the crystal.  Ensuring that the bilayer forms is the most important 
step in the experimental process.  If the bilayer does not form, then the experiment cannot 
proceed since the nanoparticle solutions would not have a suitable surface on which to interact.  
This is why several precautions need to be taken, such as cleaning the crystals very thoroughly 
and ensuring that no air enters the QCM-D chambers. 
4.1.1 Citrate Stabilized NP in Water 
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Figure 1: QCM-D plot of f and d over time for citrate stabilized NP solution in water. The graph shows 
chamber 4 of the experiment conducted on 1/9/14. NPs were introduced into the system at 38 minutes and 
water was reintroduced at 48 minutes. 
 Figure 1 shows the frequency and dissipation of the citrate stabilized NP solution in water 
over time.  After the bilayer forms there is a period where both frequency and dissipation 
stabilize. At around 30 minutes there is an increase in frequency and a decrease in dissipation, 
this is from the NPs entering the system. A small change in mass is shown before the system 
stabilizes, signifying that the NPs interacted with the system. 
 
Figure 2: The average change of mass for each overtone, with error bars, for citrate stabilized NPs in water. 
 Figure 2 shows the average error in the change of mass for each of the five overtones 
caused by the introduction of the NPs. For all five of the overtones the average change in mass is 
negative. A standard error was calculated for each overtone, and plotted with the average change 
in mass. The error associated with overtones five, nine, and eleven were all relatively small 
showing that the collected data is close to the true value of the change in mass. Overtone three 
shows a standard error that is almost equal to the average change in mass, showing that the true 
value could be potentially double that of the average. For overtone seven the average change in 
mass is relatively low compared to the standard error. The low average change in mass and the 
large error values are a product of a large negative frequency change caused by system noise.  
Since the change in mass on all overtones is negative, it appears that the NPs are penetrating the 
lipid bilayer such that pores result on the surface of the bilayer. 
4.1.2 Functionalized NP in Water 
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Figure 3: QCM-D plot of f and d over time for functionalized NP solution in water. The graph shows 
chamber 4 of the experiment conducted on 1/10/14. NPs were introduced into the system at 26 minutes and 
water was reintroduced at 36 minutes. 
Figure 3 shows the frequency and dissipation of the functionalized NP solution in water 
over time.  After the bilayer forms, there is a period of stabilization during which the buffer 
solution is flowing through the QCM-D.  At approximately twenty minutes, the frequency 
increases slightly and stabilizes, while the dissipation stays approximately the same.  It is 
difficult to tell whether or not the dissipation changes, since one of the dissipations is very noisy.  
However, this figure shows a large change in mass at twenty minutes when the water flows 
through the system, and a smaller change in mass when the nanoparticle solution in water flows 
through the system. 
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Figure 4: The average change of mass for each overtone, with error bars, for functionalized NPs in water. 
 Figure 4 shows the average error in the change of mass for each of the five overtones 
caused by the introduction of the NPs. For all five of the overtones the average change in mass is 
positive. A standard error was calculated for each overtone, and plotted with the average change 
in mass. All five overtones show an extremely large standard error. Both the positive change in 
mass and the large standard error are due to the large drop in frequency when water was 
reintroduced to the system.  Since the change in mass is positive, it appears that the NPs are 
deposited on the surface of the bilayer without penetration. 
4.1.3 Citrate Stabilized NP in Humic Acid 
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Figure 5: QCM-D plot of f and d over time for citrate stabilized NP solution in humic acid. The graph shows 
chamber 2 of the experiment conducted on 1/13/14. HA was introduced into the system at 23 minutes with 
NPs being introduced at 31 minutes. HA was reintroduced into the system at 42 minutes. 
Figure 5 shows the frequency and dissipation of the citrate stabilized NP solution in 
humic acid over time.  After the bilayer forms, there is a period of stabilization during which the 
buffer solution is flowing through the QCM-D.  At approximately twenty minutes, the frequency 
increases slightly and stabilizes, while the dissipation decreases slightly and stabilizes.  This is a 
response to a change in mass, and it indicates that the water, followed by humic acid, is flowing 
through the system.  After the water and the humic acid flow through the system, another, even 
smaller, shift in frequency and dissipation occurs.  This next change in mass is a sign that the 
nanoparticle solution in humic acid is flowing through the system.  
 Figure 6: The average change of mass for each overtone, with error bars, for citrate stabilized NPs in HA. 
 Figure 6 shows the average error in the change of mass for each of the five overtones 
caused by the introduction of the NPs. The five overtones show a mix of positive and negative 
change in mass. A standard error was calculated for each overtone, and plotted with the average 
change in mass. The standard error of each overtone was calculated to be relatively large, and 
caused by an outlier in the experimental data. The positive change of mass in overtones seven 
and eleven signify that the NPs are deposited on the bilayer surface without penetration. The 
negative change in mass in overtones three, five, and nine show that the NPs penetrated the 
bilayer creating a pores on the bilayers surface. 
4.1.4 Functionalized NP in Humic Acid 
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Figure 7: QCM-D plot of f and d over time for functionalized NP solution in humic acid. The graph shows 
chamber 3 of the experiment conducted on 1/30/14. HA was introduced to the system at 23 minutes with NPs 
being introduced at 32 minutes. HA was reintroduced to the system at 42 minutes. 
Figure 7 shows the frequency and dissipation of the functionalized NP solution in humic 
acid over time.  This figure shows a similar pattern to that of Figure 5, except that the frequency-
dissipation shift that indicates the bilayer formation is more prominent.  This is probably because 
the PC solution that was used in this experiment was more recent. 
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Figure 8: The average change of mass for each overtone, with error bars, for functionalized NPs in HA. 
 Figure 8 shows the average error in the change of mass for each of the five overtones 
caused by the introduction of the NPs. For all five of the overtones the average change in mass is 
positive. A standard error was calculated for each overtone, and plotted with the average change 
in mass. Since the change in mass is positive it can be assumed that the NPs accumulated on the 
surface of the bilayer. The relatively large standard error of overtone seven was caused by a 
rapid change in frequency at the time of NP introduction. 
  
CHAPTER 5:  CONCLUSIONS AND RECOMMENDATIONS 
 
 The effect of humic acid on the nanoparticle-membrane interaction differs between the 
two nanoparticle types. In the case of citrate stabilized NPs the introduction of HA causes a 
varied effect. Overtones three, five, and nine showed increased destabilization in HA, whereas 
overtones seven and eleven show increased stability. For the case of the functionalized NPs the 
introduction of HA significantly increases the membrane stability in all five overtones. 
 We have provided some recommendations for future experiments. First due to the 
changing nature of the environment progress should be made to approach the most realistic 
environmental situation possible. Next additional types of nanoparticles should be tested. This is 
because in industry many processes can result in the result in the release of nanoparticles either 
in air or in liquids. In addition many types of nanoparticles, at least in bulk, are known to be 
more toxic than gold. 
 We would recommend more communication between the different stakeholders in this 
problem. These stake holders include industry, government regulatory agencies, and citizens 
everywhere. Communication will allow for the spread of knowledge on nanoparticle safety, 
which will affect changes on how the different stakeholders work, such as better industry 
regulations and infrastructure.  
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APPENDIX 
Appendix 1: Raw Data 
Citrate-stabilized NP in HA sample: 
Chamber 2: 
Time (s) Time (min) 
Frequency 
(OT 3) 
Frequency 
 (OT 5) 
Frequency 
 (OT 7) 
Frequency 
 (OT 9) 
Frequency 
 (OT 11) 
Dissipation 
(OT 3) 
Dissipation 
 (OT 5) 
Dissipation 
 (OT 7) 
Dissipation 
 (OT 9) 
Dissipation 
(OT 11) 
2.157 0.03595 -5.86E-10 2.75E-10 1.24E-10 -6.89E-10 1.38E-10 0 0 0 0 0 
4.219 0.070317 0.004088 -0.13816 -0.08034 -0.0953 -0.12313 0.017305 -0.07381 0.036112 0.143511 0.021978 
6.313 0.105217 -0.00235 -0.07141 -0.07121 -0.0695 0.0258 0.014154 -0.11193 0.027952 0.080317 -0.03676 
8.407 0.140117 -0.11621 -0.04909 -0.13063 -0.00658 -0.11935 0.029068 -0.10509 0.035833 0.086578 0.021113 
10.485 0.17475 -0.14074 -0.23052 -0.21023 -0.23015 -0.26563 0.011307 -0.08455 -0.0014 0.133449 -0.05125 
12.688 0.211467 -0.24882 -0.19206 -0.22607 -0.14332 -0.31847 0.006291 -0.13284 -0.00095 0.170292 0.076243 
14.766 0.2461 -0.14412 -0.28199 -0.39155 -0.09781 -0.38519 0.01928 -0.11221 0.036102 0.159246 0.041479 
16.813 0.280217 -0.34623 -0.34776 -0.3763 -0.21835 -0.38238 -0.00101 -0.05826 -0.00992 0.104841 0.053911 
18.875 0.314583 -0.14863 -0.14866 -0.20737 -0.16079 -0.08198 0.017261 -0.08433 0.037484 0.119309 -0.01147 
20.953 0.349217 -0.30481 -0.0608 -0.3037 -0.12296 -0.16186 -0.00174 -0.07515 0.016694 0.102854 -0.05611 
23.094 0.3849 -0.12456 -0.3289 -0.14661 -0.27018 -0.23765 0.018294 -0.03016 0.028504 0.157429 0.029023 
25.172 0.419533 -0.23775 -0.3399 -0.27381 -0.18393 -0.12834 0.048621 -0.02087 0.009659 0.165684 0.05058 
27.25 0.454167 -0.3404 -0.3561 -0.35109 -0.45979 -0.2932 0.053707 -0.07548 0.032977 0.120592 0.028494 
29.328 0.4888 -0.25967 -0.14064 -0.32538 -0.48579 -0.21093 0.028549 -0.07496 0.008309 0.098234 0.014201 
31.641 0.52735 -0.26559 -0.37489 -0.33028 -0.27343 -0.30246 0.038026 -0.02877 0.064983 0.125296 0.028414 
33.75 0.5625 -0.28332 -0.18459 -0.36912 -0.14883 -0.36044 0.086237 -0.09518 0.029946 0.163716 0.027897 
35.844 0.5974 -0.51155 -0.46791 -0.44598 -0.3498 -0.36034 0.05528 -0.11206 0.069159 0.13534 0.034271 
37.969 0.632817 -0.34815 -0.17996 -0.35463 -0.37705 -0.50301 0.136546 -0.09478 0.047717 0.185073 0.016523 
40.063 0.667717 -0.43978 -0.47083 -0.44963 -0.34556 -0.46281 0.042789 -0.06166 0.07172 0.151187 0.072672 
42.157 0.702617 -0.54304 -0.36215 -0.43983 -0.55156 -0.29474 0.106475 -0.10185 -0.00193 0.156374 0.009323 
44.235 0.73725 -0.37724 -0.33506 -0.41579 -0.27688 -0.36537 0.077637 -0.06817 0.036159 0.231141 0.092053 
46.36 0.772667 -0.34554 -0.13068 -0.3447 -0.32815 -0.32111 0.059592 -0.11472 0.014642 0.087921 -0.0034 
48.453 0.80755 -0.37477 -0.23987 -0.32351 -0.3756 -0.32703 0.103 -0.06822 0.051072 0.207281 -0.0098 
50.594 0.843233 -0.35603 -0.21262 -0.34961 -0.38836 -0.19599 0.131038 -0.0742 0.048379 0.153102 0.063075 
52.672 0.877867 -0.37515 -0.31911 -0.31395 -0.37077 -0.22911 0.142618 -0.07139 0.030185 0.114526 0.04267 
54.797 0.913283 -0.23152 -0.20082 -0.26105 -0.30019 -0.06156 0.082573 -0.03712 0.019274 0.183535 -0.02873 
56.891 0.948183 -0.18969 -0.14409 -0.316 -0.13457 -0.0467 0.065167 -0.04816 0.03548 0.081593 0.00931 
59.032 0.983867 -0.17593 -0.28341 -0.32987 -0.22909 -0.04519 0.143907 0.021655 0.059009 0.175252 -0.02124 
 
Appendix 2: Sigma Plots 
Citrate stabilized NP in HA: 
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Citrate stabilized NP in Water: 
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Functionalized NP in HA: 
1/30/14 
Chamber 1
Time (min.)
0 10 20 30 40 50 60
F
re
q
u
e
n
c
y
 (
H
z
)
-70
-60
-50
-40
-30
-20
-10
0
10
D
is
s
ip
a
ti
o
n
 (
1
E
-6
)
-2
-1
0
1
2
3
4
 
Chamber 2
Time (min.)
0 10 20 30 40 50 60
F
re
q
u
e
n
c
y
 (
H
z
)
-70
-60
-50
-40
-30
-20
-10
0
10
D
is
s
ip
a
ti
o
n
 (
1
E
-6
)
-2
-1
0
1
2
3
4
 
Chamber 3
Time (min.)
0 10 20 30 40 50 60
F
re
q
u
e
n
c
y
 (
H
z
)
-70
-60
-50
-40
-30
-20
-10
0
10
D
is
s
ip
a
ti
o
n
 (
1
E
-6
)
-15
-10
-5
0
5
10
15
20
 
Chamber 4
Time (min.)
0 10 20 30 40 50 60
F
re
q
u
e
n
c
y
 (
H
z
)
-70
-60
-50
-40
-30
-20
-10
0
10
D
is
s
ip
a
ti
o
n
 (
1
E
-6
)
-2
-1
0
1
2
3
4
 
 
Functionalized NP in Water: 
1/10/14 
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Appendix 3: Error Bar Charts 
Citrate stabilized NP in HA: 
 
Citrate stabilized NP in Water: 
 
Functionalized NP in HA: 
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